Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alon Haim

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Endocrine|May 24, 2023
Open-source automated insulin delivery systems (OS-AIDs) in a pediatric population with type 1 diabetes in a real-life setting: the AWeSoMe study group experienceJudith Nir, Marianna Rachmiel, Abigail Fraser, et al.
American Journal of Epidemiology|June 28, 2021
Associations Between Prenatal Exposure to Air Pollution and Congenital HypothyroidismRuthie Harari-Kremer, Ronit Calderon-Margalit, Tim I M Korevaar, et al.
American Journal of Medical Genetics. Part A|January 13, 2021
Aldosterone synthase (CYP11B2) deficiency among Palestinian infants: Three novel variants and genetic heterogeneityYaniv Faingelernt, Eli Hershkovitz, Bassam Abu-Libdeh, et al.
Frontiers in Pediatrics|August 8, 2022
Hypoparathyroidism-retardation-dysmorphism syndrome-Clinical insights from a large longitudinal cohort in a single medical centerOdeya David, Rotem Agur, Rosa Novoa, et al.
Endocrine|January 15, 2024
A comparison of the usage of an open-source automated insulin delivery system and the MiniMed™ 780 G system in children and adolescents with type 1 diabetes in real-world settings: the AWeSoMe study groupZohar Landau, Yael Lebenthal, Kineret Mazor-Aronovitch, et al.
International Journal of Molecular Sciences|December 5, 2019
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia<sup>®</sup>) in the Treatment of Recent-Onset Type 1 DiabetesYael Lebenthal, Avivit Brener, Eli Hershkovitz, et al.
The Journal of Clinical Endocrinology and Metabolism|July 15, 2024
Insights Into Central Congenital Hypothyroidism: A Multicenter Retrospective AnalysisAlina German, Shlomo Almashanu, Liat de Vries, et al.
Pediatric Diabetes|June 16, 2015
Alpha-1 antitrypsin therapy is safe and well tolerated in children and adolescents with recent onset type 1 diabetes mellitusMarianna Rachmiel, Pnina Strauss, Nitzan Dror, et al.
Acta Diabetologica|May 18, 2024
An "out of the box" approach for prevention of ketoacidosis in youth with poorly controlled type 1 diabetes: combined use of insulin pump and long-acting insulinGalia Barash, Liat Lerman, Tal Ben-Ari, et al.
Pediatric Diabetes|December 5, 2021
Alarming increase in ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the first wave of the COVID-19 pandemic in IsraelShira Goldman, Orit Pinhas-Hamiel, Adi Weinberg, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Endocrine|May 24, 2023
Open-source automated insulin delivery systems (OS-AIDs) in a pediatric population with type 1 diabetes in a real-life setting: the AWeSoMe study group experienceJudith Nir, Marianna Rachmiel, Abigail Fraser, et al.
American Journal of Epidemiology|June 28, 2021
Associations Between Prenatal Exposure to Air Pollution and Congenital HypothyroidismRuthie Harari-Kremer, Ronit Calderon-Margalit, Tim I M Korevaar, et al.
American Journal of Medical Genetics. Part A|January 13, 2021
Aldosterone synthase (CYP11B2) deficiency among Palestinian infants: Three novel variants and genetic heterogeneityYaniv Faingelernt, Eli Hershkovitz, Bassam Abu-Libdeh, et al.
Frontiers in Pediatrics|August 8, 2022
Hypoparathyroidism-retardation-dysmorphism syndrome-Clinical insights from a large longitudinal cohort in a single medical centerOdeya David, Rotem Agur, Rosa Novoa, et al.
Endocrine|January 15, 2024
A comparison of the usage of an open-source automated insulin delivery system and the MiniMed™ 780 G system in children and adolescents with type 1 diabetes in real-world settings: the AWeSoMe study groupZohar Landau, Yael Lebenthal, Kineret Mazor-Aronovitch, et al.
International Journal of Molecular Sciences|December 5, 2019
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia<sup>®</sup>) in the Treatment of Recent-Onset Type 1 DiabetesYael Lebenthal, Avivit Brener, Eli Hershkovitz, et al.
The Journal of Clinical Endocrinology and Metabolism|July 15, 2024
Insights Into Central Congenital Hypothyroidism: A Multicenter Retrospective AnalysisAlina German, Shlomo Almashanu, Liat de Vries, et al.
Pediatric Diabetes|June 16, 2015
Alpha-1 antitrypsin therapy is safe and well tolerated in children and adolescents with recent onset type 1 diabetes mellitusMarianna Rachmiel, Pnina Strauss, Nitzan Dror, et al.
Acta Diabetologica|May 18, 2024
An "out of the box" approach for prevention of ketoacidosis in youth with poorly controlled type 1 diabetes: combined use of insulin pump and long-acting insulinGalia Barash, Liat Lerman, Tal Ben-Ari, et al.
Pediatric Diabetes|December 5, 2021
Alarming increase in ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the first wave of the COVID-19 pandemic in IsraelShira Goldman, Orit Pinhas-Hamiel, Adi Weinberg, et al.
Pageof 7